ArticleInternational urogynecology journal2026
Urinary Functional Outcomes and Prolapse Recurrence After Laparoscopic Sacrocolpopexy: A 400-Patient Single-Centre Study.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisLaparoscopic sacrocolpopexy (LSC) is the reference surgical treatment for pelvic organ prolapse (POP), providing durable anatomical correction with a favourable safety profile. However, postoperative urinary symptom evolution remains incompletely characterized. We aimed to evaluate the surgical and functional outcomes of LSC and identify factors associated with postoperative urinary symptoms.
methodsThis retrospective observational study included 400 consecutive women who underwent LSC for POP between 2011 and 2025. In accordance with our institutional staged continence-management strategy, no concomitant anti-incontinence procedures were performed. Surgical complications, prolapse recurrence, and urinary outcomes were evaluated. Persistent, resolved, and de novo stress urinary incontinence (SUI) and urgency urinary incontinence (UUI) were assessed. Univariable logistic regression identified factors associated with postoperative urinary symptoms and prolapse recurrence.
resultsMedian follow-up was 30 months (interquartile range [IQR] 15-48). Intraoperative complications occurred in 7.8% of patients, mainly bladder (3.5%) and vaginal (2.0%) injuries. Overall prolapse recurrence was 7.8%. Preoperative SUI and UUI were present in 38% and 41% of patients, respectively. UUI prevalence decreased to approximately 15% postoperatively, whereas SUI remained close to 29%. Persistent SUI and UUI occurred in 38% and 23% of symptomatic patients, while de novo SUI and UUI developed in 23% and 9%, respectively. Preoperative urinary symptoms were the only significant predictors of postoperative urinary symptoms.
conclusionsLSC performed without concomitant anti-incontinence surgery was associated with favourable urinary outcomes, particularly for urgency symptoms. Preoperative urinary symptoms were the strongest predictors of postoperative urinary outcomes, emphasizing the importance of comprehensive preoperative assessment and individualized patient counselling.
Indexed as
Identifiers
42782524What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.